tradingkey.logo
tradingkey.logo
Search

Silence Therapeutics PLC

SLN
Add to Watchlist
11.220USD
-0.290-2.52%
Close 09-24 16:00(ET)
697.37MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.52%

5 Days

-10.24%

1 Month

-15.45%

6 Months

+94.29%

Year to Date

+84.54%

1 Year

+117.86%

Key Figures

11.500Open
12.350High
85.52KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
11.510Prev. Close
11.060Low
973.92KTurnover
LossP/E Static
18.11P/B
0.00%Div Yield TTM
-49.96%ROA
17.57652wk High
0.11Volume Ratio
-45.31MNet Profit
62.15MShares
-1.5886EPS TTM
1.49Beta
-92.56%ROE
4.19052wk Low
11.21%Amplitude
97.39%Gross Margin
697.37MMarket Cap
6.07Reward/Risk
5.36%Risk Rate
More news coming soon, stay tuned...

Silence Therapeutics PLC's Score

0.09vs previous score
Forecast8.00
Financial Health6.65
Technical4.64
Valuation Dimensions9.22
Institutional Confidence3.00
Risk Assessment3.31

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
35.800Target Price
+211.03%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy22222222
Buy44433333
Hold00000000
Sell11111111
Strong Sell00000000

Silence Therapeutics PLC Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.26/--
Revenue / Forecast
0.00/--

Silence Therapeutics PLC Profile

SectorBiotechnology & Medical Research
Ticker SymbolSLN
Number of employees116
CountryUnited Kingdom

Ownership

ShareholdersProportion
Griffiths (Richard Ian)24.38%
TCG Crossover Management, LLC6.42%
Invus Public Equities Advisors, LLC6.16%
Redmile Group, LLC4.58%
Shareholder TypesProportion
Individual Investor24.38%
Investment Advisor18.98%
Hedge Fund9.49%
Investment Advisor/Hedge Fund7.27%

FAQs

What is the current price of Silence Therapeutics PLC (SLN)?

The current price of Silence Therapeutics PLC (SLN) is 11.51.

What is the symbol of Silence Therapeutics PLC?

The ticker symbol of Silence Therapeutics PLC is SLN.

What is the 52-week high of Silence Therapeutics PLC?

The 52-week high of Silence Therapeutics PLC is 17.58.

What is the 52-week low of Silence Therapeutics PLC?

The 52-week low of Silence Therapeutics PLC is 4.19.

What is the market capitalization of Silence Therapeutics PLC?

The market capitalization of Silence Therapeutics PLC is 715.39M.

Is Silence Therapeutics PLC (SLN) currently rated as Buy, Hold, or Sell?

According to analysts, Silence Therapeutics PLC (SLN) has an overall rating of Buy, with a price target of 35.80.

What is the Earnings Per Share (EPS TTM) of Silence Therapeutics PLC (SLN)?

The Earnings Per Share (EPS TTM) of Silence Therapeutics PLC (SLN) is -1.59.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.